ReviewTherapeutics and clinical risk management2022

Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic.

Matthew Feldman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.